Rchr
J-GLOBAL ID：201801012345530637
Update date: Apr. 18, 2024
Kada Akiko
Kada Akiko
Affiliation and department：
Research field (2)：
Hygiene and public health (non-laboratory)
, Statistical science
Research keywords (2)：
臨床研究のデザインと解析
, 生物統計
Research theme for competitive and other funds (6)：
Papers (114)：
-
Hideo Saka, Masahide Oki, Yoshikane Yamauchi, Chiyoe Kitagawa, Akiko Kada, Akiko M Saito, Haruhiko Kondo, Hirotaka Kida, Noriaki Takahashi, Akihiro Bessho, et al. Talc slurry pleurodesis in patients with secondary intractable pneumothorax: A phase 2 study. Respiratory investigation. 2024. 62. 2. 277-283
-
Tetsuya Mori, Tomoo Osumi, Akiko Kada, Kentaro Ohki, Yuhki Koga, Reiji Fukano, Naoto Fujita, Tetsuo Mitsui, Takeshi Mori, Akiko M Saito, et al. Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell non-Hodgkin lymphoma: A report from the JPLSG B-NHL14 trial. European journal of haematology. 2023
-
Yoshihito Kogure, Akiko Kada, Hiroya Hashimoto, Shinji Atagi, Yuichi Takiguchi, Hideo Saka, Noriyuki Ebi, Akira Inoue, Takayasu Kurata, Yuka Fujita, et al. Survival Impact of Second-Line Immune Checkpoint Inhibitors in Older Patients With Advanced Squamous-Cell NSCLC: Post Hoc Analysis of the CAPITAL Study. JTO clinical and research reports. 2023. 4. 6. 100514-100514
-
Ryota Kurogi, Akiko Kada, Kuniaki Ogasawara, Kunihiro Nishimura, Takanari Kitazono, Toru Iwama, Yuji Matsumaru, Nobuyuki Sakai, Yoshiaki Shiokawa, Shigeru Miyachi, et al. National trends in the outcomes of subarachnoid haemorrhage and the prognostic influence of stroke centre capability in Japan: retrospective cohort study. BMJ Open. 2023. 13. 4. e068642-e068642
-
Ai Kurogi, Daisuke Onozuka, Akihito Hagihara, Kunihiro Nishimura, Akiko Kada, Manabu Hasegawa, Takahiro Higashi, Takanari Kitazono, Tsuyoshi Ohta, Nobuyuki Sakai, et al. Influence of hospital capabilities and prehospital time on outcomes of thrombectomy for stroke in Japan from 2013 to 2016. Scientific Reports. 2022. 12. 1
ｍore...
MISC (42)：
-
堀 大紀, 小林 良二, 中澤 温子, 岩淵 英人, Klapper Wolfram, 大隈 朋生, 藤田 直人, 三井 哲夫, 古賀 友紀, 森 健, et al. 日本の小児びまん性大細胞型B細胞リンパ腫における非胚中心B細胞型(non-GCB)の検討. 日本血液学会学術集会. 2022. 84回. 918-918
-
橋本大哉, 嘉田晃子. 小標本の制限付き平均生存時間の推定に対する打ち切りの影響. 統計関連学会連合大会講演報告集. 2022. 2022
-
橋本大哉, 嘉田晃子. 制限付き平均生存時間に対する変数変換を用いた信頼区間推定. 日本計量生物学会年会講演予稿集. 2022. 2022
-
Atsushi Sato, Hirohide Kawasaki, Takao Deguchi, Yoshiko Hashii, Yuka Iijima-Yamashita, Sachiko Yonezawa, Chiyo K. Imamura, Haruko Shima, Hirotoshi Sakaguchi, Yuichi Kodama, et al. Chemotherapy with the Use of TKIs Based on MRD Has the Potential to Avoid Hematopoietic Stem Cell Transplantation in Treatment for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL). Results of the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Study ALL-Ph13. BLOOD. 2021. 138
-
嶋 晴子, 佐藤 伊織, 上別府 圭子, 嘉田 晃子, 谷澤 昭彦, 遠野 千佳子, 伊藤 正樹, 渡辺 輝浩, 湯坐 有希, 瓜生 英子, et al. 長期TKI治療後の小児CML患者における無治療寛解の効果(Impact of TFR on adverse events and QOL in children with long-term exposure to TKI for CML). 日本血液学会学術集会. 2021. 83回. OS1-5
ｍore...
Return to Previous Page
